Rapport Therapeutics, Inc. Stock Performance
as on November 3, 2026 at 2:15 pm IST
Day's Low
Day's High
$24.22$26.16
3.62%
Downside
4.10%
Upside
52 Week's Low
52 Week's High
$22.06$52.9312.21%
Downside
110.62%
Upside
Rapport Therapeutics, Inc. share price movements today
- Previous Close
- $25.05
- Open
- $25.32
- Volume
- 606.9K
- Market Cap
- $1.4B
- Day's Low - High
- $24.22 - $26.16
- 52 Week Low - High
- $22.06 - $52.93
Rapport Therapeutics, Inc. Historical Returns
- 1 Month Return
- -21.88 %
- 3 Month Return
- -38.39 %
- 1 Year Return
- -6.72 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Rapport Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Rapport Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-3.04
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-8.24
Industry PE ratio
-7.24
PEG Ratio
0.38
EBITDA
-148.4M
Revenue (TTM)
20.0M
Profit Margin
100.00%
Return On Equity TTM
-29.02%
Rapport Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Rapport Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.4B | NA | -8.24 | 100.00% | 0.00% | |
| Neutral | $88.5B | -36.16% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 192.56% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 47.41% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Rapport Therapeutics, Inc. Stock including INR - Dollar returns
The Rapport Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Rapport Therapeutics, Inc. investment value today
Current value as on today
₹99,775
Returns
Returns from Rapport Therapeutics, Inc. Stock
Dollar Impact
₹6,494 (+6.49%)
Analyst Recommendation on Rapport Therapeutics, Inc. Stock
Based on 10 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Rapport Therapeutics, Inc.. Average target price of $71.2857142857143
Rapport Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Rapport Therapeutics, Inc..
Current Price
$25.13
Analyzed by
10 Analysts
High
$91
Low
$50
Rapport Therapeutics, Inc. target price $0, a slight upside of 0% compared to current price of $25.13. According to 10 analysts rating.
Indian Investors' Interest in Rapport Therapeutics, Inc. Stock
Search interest for Rapport Therapeutics, Inc. Stock has increased by 221% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:221% versus previous 30 day period
Rapport Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Rapport Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Rapport Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Rapport Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Rapport Therapeutics, Inc. News & Key Events
Today's Timeline - 20 October
Tue, 04:00 PM
-Rapport Therapeutics reports positive Phase 2 trial results for RAP-219, establishing clinical proof-of-concept in bipolar mania.
Tue, 05:13 PM
-Rapport Therapeutics shares surged 31.1% after positive Phase 2 trial results for RAP-219 in bipolar mania.
Tue, 05:20 PM
-Wells Fargo notes positive efficacy for RAP-219 but raises concerns about safety and stock upside limitations.
Today's Timeline - 20 October
Tue, 09:40 PM
-H.C. Wainwright raises price target for Rapport Therapeutics to $66, maintaining a Buy rating after positive trial results.
Tue, 10:15 PM
-Raymond James raises Rapport Therapeutics price target to $86, maintaining a Strong Buy rating despite market concerns.
Insights on Rapport Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 793.2%
NEGATIVE IMPACTPrice Dip
In the last 7 days, RAPP stock has moved down by -8.8%
About Rapport Therapeutics, Inc.
| Organisation | Rapport Therapeutics, Inc. |
| Headquarters | 99 High Street, Boston, MA, 02110, US |
| Industry | Biotechnology |
| CEO | Abraham N. Ceesay |
Key Management of Rapport Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Troy A. Ignelzi | Chief Financial Officer |
Ms. Karina Chmielewski | Chief Information Officer & Head of Operations |
Ms. Julie DiCarlo | Head of Communications & Investor Relations |
Ms. Kathleen A. Wilkinson | Chief People Officer |
Dr. Steven M. Paul M.D. | Founder & Independent Chairman |
Mr. Abraham N. Ceesay M.B.A. | CEO, President, Treasurer & Director |
FAQs
What is Rapport Therapeutics, Inc. share price today?
Rapport Therapeutics, Inc. share price today is $25.13 as on at the close of the market. Rapport Therapeutics, Inc. share today touched a day high of $26.16 and a low of $24.22.
What is the 52 week high and 52 week low for Rapport Therapeutics, Inc. share?
Rapport Therapeutics, Inc. share touched a 52 week high of $52.93 on and a 52 week low of $22.06 on . Rapport Therapeutics, Inc. stock price today i.e. is closed at $25.13,which is 52.52% down from its 52 week high and 13.91% up from its 52 week low.
What is Rapport Therapeutics, Inc.'s market capitalisation today?
Rapport Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Rapport Therapeutics, Inc. Stock (RAPP) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Rapport Therapeutics, Inc. on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Rapport Therapeutics, Inc. Stock (RAPP) from India?
Indian investors can start investing in Rapport Therapeutics, Inc. (RAPP) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Rapport Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rapport Therapeutics, Inc. share’s latest price of $25.13 as on November 3, 2026 at 8:45 am IST, you will get 0.3979 shares of Rapport Therapeutics, Inc.. Learn more about
fractional shares .